BACKGROUND: Women may experience distress or changes in their quality of life following treatment for early-stage melanoma. In order to plan future interventions and identify areas of primary concern, we conducted a cross-sectional survey to describe the experiences of women treated for clinically localized melanoma. METHODS: We examined quality of life, levels of distress, appearance perceptions, body image, fear of recurrence, and reproductive concerns in 100 patients (age 21-90 years, M = 54.34 years). Most (61 %) had melanoma of the extremity, with a median depth of 1.1 mm (range, 0-10.5 mm). RESULTS: Significant depressive symptomatology occurred in 10 % of patients, and 12 % reported a clinically established high level of intrusive thoughts related to melanoma. Quality-of-life scores indicated more disruption on psychological, compared with social and physical functioning. Also, 64 % of women rated their appearance as worse post-treatment; 23 % were unsatisfied with the appearance of the surgical site. Recurrence concerns indicated significant worry about health and death. Most patients (>85 %) were not concerned about fertility, but 52 % worried that future children would have an increased risk of cancer. CONCLUSIONS: Some women treated for clinically localized melanoma reported high levels of distress associated with their altered body image and fear of recurrence. Improvements in patient education prior to surgical intervention may reduce the distress associated with the diagnosis and treatment of melanoma.
BACKGROUND:Women may experience distress or changes in their quality of life following treatment for early-stage melanoma. In order to plan future interventions and identify areas of primary concern, we conducted a cross-sectional survey to describe the experiences of women treated for clinically localized melanoma. METHODS: We examined quality of life, levels of distress, appearance perceptions, body image, fear of recurrence, and reproductive concerns in 100 patients (age 21-90 years, M = 54.34 years). Most (61 %) had melanoma of the extremity, with a median depth of 1.1 mm (range, 0-10.5 mm). RESULTS: Significant depressive symptomatology occurred in 10 % of patients, and 12 % reported a clinically established high level of intrusive thoughts related to melanoma. Quality-of-life scores indicated more disruption on psychological, compared with social and physical functioning. Also, 64 % of women rated their appearance as worse post-treatment; 23 % were unsatisfied with the appearance of the surgical site. Recurrence concerns indicated significant worry about health and death. Most patients (>85 %) were not concerned about fertility, but 52 % worried that future children would have an increased risk of cancer. CONCLUSIONS: Some women treated for clinically localized melanoma reported high levels of distress associated with their altered body image and fear of recurrence. Improvements in patient education prior to surgical intervention may reduce the distress associated with the diagnosis and treatment of melanoma.
Authors: Candyce H Kroenke; Gary G Bennett; Charles Fuchs; Ed Giovannucci; Ichiro Kawachi; Eva Schernhammer; Michelle D Holmes; Laura D Kubzansky Journal: Am J Epidemiol Date: 2005-10-05 Impact factor: 4.897
Authors: Susan A Oliveria; Elyse Shuk; Jennifer L Hay; Maureen Heneghan; Jacqueline M Goulart; Katherine Panageas; Alan C Geller; Allan C Halpern Journal: Psychooncology Date: 2011-10-06 Impact factor: 3.894
Authors: Eleni Linos; Susan M Swetter; Myles G Cockburn; Graham A Colditz; Christina A Clarke Journal: J Invest Dermatol Date: 2009-01-08 Impact factor: 8.551
Authors: Andreas Dinkel; Marielouise Kornmayer; Jürgen E Gschwend; Birgitt Marten-Mittag; Peter Herschbach; Kathleen Herkommer Journal: Fam Cancer Date: 2014-09 Impact factor: 2.375
Authors: Oxana Palesh; Arianna Aldridge-Gerry; Kelly Bugos; David Pickham; Jie Jane Chen; Ralph Greco; Susan M Swetter Journal: Support Care Cancer Date: 2014-05-31 Impact factor: 3.603
Authors: Bonnie E Gould Rothberg; Kaleigh J Bulloch; Judith A Fine; Raymond L Barnhill; Marianne Berwick Journal: Cancer Epidemiol Date: 2014-09-05 Impact factor: 2.984
Authors: Rachel I Vogel; Broderick Yoerg; Patricia I Jewett; Nathan Rubin; Megan Olson; Ashley E Stenzel; Rehana L Ahmed; DeAnn Lazovich Journal: Support Care Cancer Date: 2021-02-12 Impact factor: 3.359
Authors: Carmen Loquai; Vera Scheurich; Nils Syring; Irene Schmidtmann; Stephan Rietz; Andreas Werner; Stephan Grabbe; Manfred E Beutel Journal: PLoS One Date: 2013-07-05 Impact factor: 3.240